๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Planar chromatographic separation of enantiomers and diastereomers with cyclodextrin mobile phase additives

โœ Scribed by Daniel W. Armstrong; Feng-Ying He; Soon M. Han


Book ID
104145777
Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
633 KB
Volume
448
Category
Article
ISSN
1873-3778

No coin nor oath required. For personal study only.

โœฆ Synopsis


A variety of racemic compounds were resolved using reversed-phase thin-layer chromatography (TLC) with mobile phases containing highly concentrated solutions of fi-cyclodextrin (P-CD). These include the drugs labetalol and mephenytoin, metallocenes, crown ethers, methyl-p-toluenesulfinate, nornicotine derivatives and several dansyl and fi-naphthylamide substituted amino acids. It was possible to resolve some racemates that could not be separated on /I-CD bonded phase liquid chromatography (LC) columns with this technique. Likewise there were some compounds that could be resolved with the LC approach that failed to separate with the present TLC method. In cases of racemates that could be resolved by either approach, it was found that the retention order was exactly opposite for the two methods. Enantiomeric resolution is highly dependent on mobile phase composition. In particular, the type and amount of organic modifier as well as the concentration of /?-CD affect the observed resolution. Possible reasons for the chromatographic behavior are discussed. Several diastereoisomeric compounds were separated as well, including steroid epimers and pharmaceutical compounds.


๐Ÿ“œ SIMILAR VOLUMES


Separation of enantiomers by microcolumn
โœ Rongzong Hu; Toyohide Takeuchi; Ji-Ye Jin; Tomoo Miwa ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 606 KB

Enantiomers can be separated by microcolumn liquid chromatography with methylated &cyclodextrin @-CD) as a mobile phase additive. Effects of the mobile phase composition on the retention behaviour of the analytes were examined. The separation factor achieved with heptakis(2,3,6-tri-0-methyl)+-CD as